The Pro Medicus share price is down 42% from its euphoric 2025 peak. Is the nosediving sentiment justified, or overdone?

There are at least 3 positive signals that make me feel much more positively about Alcidion shares than I did one year ago.

New findings from Cell on how the brain repairs itself during sleep, and the effects of sleeping pills on the process.

The fabrications of Oliver Sacks, doctor, scientist and author of The Man Who Mistook His Wife For a Hat, as revealed in New Yorker report.

Before I (GrowthGauge here) delve into the FY25 results, it is important to understand the history of events for KME. This article marks the anniversary of my coverage of KME stock, shown below. I ...

Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...

Lovisa Holdings Ltd (ASX: LOV) delivered another year of strong global growth in FY 2025, setting the stage for further expansion as a key competitor struggles. Backed by retail doyen and chairman ...

Now, as bad as it seems, the above result was expected, and the market was well informed about it prior to these results, so I don’t think these numbers drove the share price decline from around $6 ...

The PEXA Group (ASX: PXA) share price has gained over 20% to around $15.75, since it announced its agreement with NatWest to implement its technology. This milestone comes after nearly two years of ...

I (GrowthGauge) first bought LaserBond (ASX: LBL) on 5 April 2019 at $0.425. The price soon doubled, then sank to $0.28 in the COVID crash. It climbed to almost $1.00 in 2021 and has drifted since.

The last 10 years have been a wild ride for Catapult International Group (ASX: CAT) shares, as a business and for its investors. When I initially covered Catapult shares, I shared the following ...